FROM Nick Stockton
Theranos Investigations and Silicon Valley Dealmaking The bad news continues to roll in for Theranos, the Silicon Valley-based blood-testing company that was previously valued at $9 billion. Just a few years ago, the company’s wunderkind C.E.O. Elizabeth Holmes was the subject of glowing media profiles. Today, the company she founded is the subject of a criminal probe by the Justice Department, and is also being investigated by the Securities and Exchange Commission over allegations of fraud. Regulators are also considering banning Holmes from owning or running blood-testing labs for two years. How unique is a probe into a company like this? What do the investigations into Theranos say about deal making in Silicon Valley?
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.